RhumbLine Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.14B | Sell |
|
|||||
2025
Q1 | $1.24B | Buy |
|
|||||
2024
Q4 | $1.15B | Sell |
|
|||||
2024
Q3 | $1.34B | Sell |
|
|||||
2024
Q2 | $1.43B | Buy |
|
|||||
2024
Q1 | $1.2B | Sell |
|
|||||
2023
Q4 | $898M | Sell |
|
|||||
2023
Q3 | $835M | Buy |
|
|||||
2023
Q2 | $725M | Buy |
|
|||||
2023
Q1 | $525M | Buy |
|
|||||
2022
Q4 | $538M | Buy |
|
|||||
2022
Q3 | $456M | Buy |
|
|||||
2022
Q2 | $448M | Buy |
|
|||||
2022
Q1 | $387M | Buy |
|
|||||
2021
Q4 | $368M | Buy |
|
|||||
2021
Q3 | $302M | Sell |
|
|||||
2021
Q2 | $309M | Sell |
|
|||||
2021
Q1 | $264M | Sell |
|
|||||
2020
Q4 | $255M | Sell |
|
|||||
2020
Q3 | $227M | Sell |
|
|||||
2020
Q2 | $255M | Buy |
|
|||||
2020
Q1 | $201M | Sell |
|
|||||
2019
Q4 | $193M | Sell |
|
|||||
2019
Q3 | $166M | Buy |
|
|||||
2019
Q2 | $161M | Sell |
|
|||||
2019
Q1 | $198M | Sell |
|
|||||
2018
Q4 | $178M | Buy |
|
|||||
2018
Q3 | $164M | Sell |
|
|||||
2018
Q2 | $133M | Buy |
|
|||||
2018
Q1 | $119M | Sell |
|
|||||
2017
Q4 | $133M | Buy |
|
|||||
2017
Q3 | $132M | Sell |
|
|||||
2017
Q2 | $132M | Buy |
|
|||||
2017
Q1 | $133M | Buy |
|
|||||
2016
Q4 | $110M | Buy |
|
|||||
2016
Q3 | $117M | Buy |
|
|||||
2016
Q2 | $110M | Buy |
|
|||||
2016
Q1 | $96.6M | Buy |
|
|||||
2015
Q4 | $110M | Sell |
|
|||||
2015
Q3 | $110M | Sell |
|
|||||
2015
Q2 | $109M | Sell |
|
|||||
2015
Q1 | $110M | Sell |
|
|||||
2014
Q4 | $106M | Sell |
|
|||||
2014
Q3 | $101M | Sell |
|
|||||
2014
Q2 | $97.9M | Sell |
|
|||||
2014
Q1 | $96.6M | Sell |
|
|||||
2013
Q4 | $85.3M | Sell |
|
|||||
2013
Q3 | $86.8M | Sell |
|
|||||
2013
Q2 | $86.1M | Buy |
|